via

AI-Supported, Single-Center Cancer Model from Liv Hospital

Photo: Liv Hospital via FL Communications ISTANBUL, July 17, 2025 (GLOBE NEWSWIRE) -- The “single-center oncology model,” implemented by only…

1 week ago

Via announces confidential submission of draft registration statement related to proposed public offering

NEW YORK, July 16, 2025 /PRNewswire/ -- Via Transportation, Inc. today announced that it has confidentially submitted a draft registration…

1 week ago

Branded Legacy Inc. Announces Leadership Transition and Pending Merger with Innovative Addiction Therapeutics Company Projecting $40 Million in First-Year Revenue

ORLANDO, Fla., July 14, 2025 (GLOBE NEWSWIRE) -- via IBN -- Branded Legacy Inc. (OTC: BLEG), a diversified holdings company,…

2 weeks ago

METABORA Partners with LINE NEXT to Distribute Web3 Games via Mini Dapp

METABORA becomes core partner in web3 game development for LINE NEXT's Dapp Portal BORA Utility to Expand through in-game payments…

2 weeks ago

Medical Device Manufacturers Accelerate R&D and Speed to Market via Live Prototyping

BOSTON, July 10, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization (CDMO) for industry-leading, multi-national healthcare…

2 weeks ago

Euro NCAP to Launch New Round of 2025 Safety Results

WhatLatest Euro NCAP safety results published online and via social media.WhenWednesday 9 July - 11:00 a.m. CEST.WhereGo to Euro NCAP's…

3 weeks ago

PR Newswire Expands Reach in Singapore via SPH Media Partnership

Collaboration unlocks premium visibility across Singapore's top news and finance platforms, empowering clients to engage broader audiences with greater impact.…

3 weeks ago

CEA Opens ShanghaiAucklandBuenos Aires “New International Land-Sea Trade Corridor” to First Bridge China and South America

SHANGHAI--(BUSINESS WIRE)--On June 18, 2025, China Eastern Airlines (CEA) and Auckland Airport signed a cooperation agreement in Shanghai. According to…

1 month ago

Press Release: Rilzabrutinib granted orphan drug designation in the US for sickle cell disease

Rilzabrutinib granted orphan drug designation in the US for sickle cell disease Fourth orphan drug designation for rilzabrutinib in rare…

2 months ago